Sfoglia per Correlatore
Mostrati risultati da 1 a 3 di 3
Belimumab efficacy on different subsets of musculoskeletal features in patients with systemic lupus erythematosus treated in real world setting. Results from a multicentric, nationwide cohort (BeRLiSS-Joint)
2023/2024 RUFFATO, ELENA
Efficacy of belimumab on specific and nonspecific skin manifestations of systemic lupus erythematosus; results from a multicentric, nationwide cohort of patients treated in a real-world setting (BeRLiSS-Skin)
2023/2024 TIZIAN, MARTINA
Predictors of minimal, moderate, and major response to Belimumab evaluated by CLASI, DAS28 and SLE-DAS. A retrospective analysis of a large nationwide multicentric cohort of SLE patients prospectively followed.
2021/2022 PROSPERO, ROSSELLA
Tipologia | Anno | Titolo | Titolo inglese | Autore | File |
---|---|---|---|---|---|
Lauree magistrali a ciclo unico | 2023 | Belimumab efficacy on different subsets of musculoskeletal features in patients with systemic lupus erythematosus treated in real world setting. Results from a multicentric, nationwide cohort (BeRLiSS-Joint) | Belimumab efficacy on different subset of musculoskeletal features in patients with systemic lupus erythematosus treated in real word setting; results from a multicentric, nationwide cohort (BeRLiSS-Joint) | RUFFATO, ELENA | |
Lauree magistrali a ciclo unico | 2023 | Efficacy of belimumab on specific and nonspecific skin manifestations of systemic lupus erythematosus; results from a multicentric, nationwide cohort of patients treated in a real-world setting (BeRLiSS-Skin) | Efficacy of belimumab on specific and nonspecific skin manifestations of systemic lupus erythematosus; results from a multicentric, nationwide cohort of patients treated in a real-world setting (BeRLiSS-Skin). | TIZIAN, MARTINA | |
Lauree magistrali a ciclo unico | 2021 | Predictors of minimal, moderate, and major response to Belimumab evaluated by CLASI, DAS28 and SLE-DAS. A retrospective analysis of a large nationwide multicentric cohort of SLE patients prospectively followed. | Predictors of minimal, moderate, and major response to Belimumab evaluated by CLASI, DAS28 and SLE-DAS. A retrospective analysis of a large nationwide multicentric cohort of SLE patients prospectively followed. | PROSPERO, ROSSELLA |
Mostrati risultati da 1 a 3 di 3
Legenda icone
- file ad accesso aperto
- file ad accesso riservato
- file sotto embargo
- nessun file disponibile